Recent studies have used ethanol stool disinfection as a mean of promoting valuable species' cultivation in bacteriotherapy trials for Clostridium difficile infections (CDI) treatment with a particular focus on sporulating bacteria. Moreover, the culturomic approach has considerably enriched the repertoire of cultivable organisms in the human gut in recent years. This study aimed to apply this culturomic approach on fecal donor samples treated with ethanol disinfection to evidence potential beneficial microbes that could be used in bacteriotherapy trials for the treatment of CDI. Thereby, a total of 254 bacterial species were identified, 9 of which were novel. Of these, 242 have never been included in clinical trials for the treatment of CDIs, representing potential new candidates for bacteriotherapy trials. While non-sporulating species were nevertheless more affected by the ethanol pretreatment than sporulating species, the ethanol disinfection technique did not specifically select bacteria able to sporulate, as suggested by previous studies. Furthermore, some bacteria previously considered as potential candidates for bacteriotherapy have been lost after ethanol treatment. This study, while enriching the bacterial repertoire of the human intestine, would nevertheless require determining the exact contribution of each of species composing the bacterial consortia intended to be administered for CDI treatment.
culturomic approach. The objective is to evaluate the panel of bacterial species isolated from these stool samples that have not been reported in previous studies and would have a potential therapeutic effect on Clostridium difficile infections (CDI).
Results
Distribution of bacterial species. The Table 1 ) and 6 different directs cultures used allowed us to test a total of 38,016 bacterial colonies by MALDI-TOF MS among the 8 fresh stool specimens. As a result, 196 bacterial species were identified, of which 99 were known in the human gut (50%), 13 in humans but not in the gut (7%), 12 unknown from human being (6%), while 63 were new species previously discovered as part of other culturomics studies (32%) 23 and 9 were new species discovered in this study (5%) (Appendix 1). The classification in phylum shows a predominance of Firmicutes (67%), followed by Actinobacteria (15%), Bacteroidetes (15%) and small portions of Proteobacteria (2%) and Synergistetes (1%) (Fig. 1A) . These species are mostly anaerobes (158/196 = 80.61%) ( Fig. 1B) . Concerning the 3 fecal infusions, a total of 16,500 colonies were tested by MALDI-TOF MS, representing 135 different species, 81 of which are already known in the human gut (60%), 12 in the human, but not in gut (9%), 8 were non-Human (6%), 34 were culturomics new species (25%), but no other new species was discovered. The same profile of phylum distribution is observed in the fecal infusions. Firmicutes represent 63%, Bacteroidetes 17%, Actinobacteria 11% followed by small portions of Proteobacteria (8%) and Synergistetes (1%) (Fig. 1C) . The majority were also anaerobes (73.33%) ( Fig. 1D) . A total of 254 bacterial species were isolated from 11 stools samples disinfected with ethanol, mainly anaerobes (194/254 = 73.83%) (Appendix 1). These species are predominated by the families Clostridiaceae (37/254 = 14.57%), Ruminococcaceae (17/254 = 6.69%), Bacteroidaceae (16/254 = 6.30%), Bacillaceae (15/254 = 5.91%) and Lachnospiraceae (13/254 = 5.12%) (Appendix 1). The richness of bacterial species obtained in stools is very variable from one stool to another (from 35 to 68 species for fresh stool and 33 to 83 for fecal infusions) (Appendix 2).
enrichment conditions (Supplementary
Overall, for each fresh stool, the proportion of new species previously known in culture and those added in this study represents a little more than one third (72/196 species = 36.73%) of the total proportion of bacterial species obtained (Appendix 1), and those found in fecal infusions represent 1/4 (34/135 species; 25.18%) of these total species (Appendix 1). For the 11 samples combined, the proportion of new species previously isolated in culturomics and those discovered following ethanol disinfection, represent 32.67% (83/254) of the total proportion of bacterial species (Appendix 1).
Impact of ethanol disinfection. The 18 usual culturomics conditions were carried out in parallel with those following ethanol disinfection on the same fecal samples. To assess the impact of ethanol disinfection, we compared the culture data obtained before and after ethanol disinfection of the same stool sample. Ethanol disinfection applied to the 8 fresh samples allows 60 species that were absent under the 18 standard cultivation conditions to be cultivated, the same figure being 49 species for the 3 fecal infusions (Fig. 2 , Appendix 1). Considering all bacterial species isolated in the 11 samples, 68 bacterial species were unique to ethanol disinfection, while 98 and 329 different species are acquired and lost at least once, respectively (Appendix 2). In detail, ethanol disinfection has eliminated bacteria such as Phascolarctobacterium faecium (Supplementary Table 2 ) and Barnesiella intestinihominis (Appendix 2), but also several species of the genera Alistipes, Bacteroides, Dialister, Bifidobacterium for which the mean differential frequency of the different species are respectively −3.81, −3.52, −3.50 and −3.33 ( Fig. 3 , Table 1 ). Species belonging to the genera Bacillus, Clostridium, Blautia, Lactobacillus and Prevotella seem to be less affected by this bacterial elimination caused by ethanol disinfection (Fig. 3 , Table 1 ). All species gained and lost in each stool with ethanol disinfection are illustrated in Appendix 2. More particularly, at the family level, we observed after ethanol disinfection an enrichment in Ruminococcaceae, Bacteroidaceae and Lachnospiraceae, whose rates decreased respectively from 2.70%, 5.16% and 4.18% before disinfection to 6.69%, 6.30% and 5.12% after disinfection (Appendix 1). Impact on spore forming species. When all samples are combined, the number of species gained at least once with ethanol disinfection was 98, 26 of which (26.53%) were sporulating species. Among the 329 species lost at least once with ethanol disinfection, 10.94% (36 species) were sporulating species (Appendix 2, Fig. 4 ). In addition, only 32.65% of the species found in both ethanol and ethanol-free conditions are sporulating (16 species). The mean impact was assessed by summing the number of samples for which the genus was gained and subtracting the number of samples for which it was lost. Each loss corresponds to the sum of the number of species belonging to this genus present before disinfection, but absent after disinfection. Each gain corresponds to the sum of the number of species belonging to this genus isolated absent before disinfection, but present after disinfection.
While these data suggest that ethanol incubation does not select only spore-forming species, non-spore-forming species are nevertheless more affected by ethanol pre-treatment than spore-forming species(p = 0.0003) ( Fig. 4 ).
Impact of the culturomics strategy on the cultivation of potential bacterial species of interest for bacteriotherapy.
Of the 71 species previously reported in bacteriotherapy trials [16] [17] [18] [19] [20] , 12 (17%) were recovered in this study ( Fig. 5A,B ). The species are as follows: Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides vulgatus, Bifidobacterium adolescentis, Bifidobacterium longum, Clostridium bifermentans, Clostridium innocuum, Clostridium ramosum, Collinsella aerofaciens, Enterococcus fecalis, Escherichia coli and Parabacteroides distasonis. In addition, 242 bacterial species isolated in this study were not considered in bacteriotherapy trials (Fig. 5B, Appendix 3) . These are mainly strict anaerobes (185/242 = 76.45%) and predominated by phyla Firmicutes (158/242), Bacteroidetes (33/242) and Actinobacteria (31/242) and with a low proportion of Each point represents a species that has been classified as sporulated or non-sporulated. We have assessed the mean impact of ethanol disinfection for each species by summing the number of samples for which the species was gained and subtracting the number of samples for which it was lost. A gain corresponds to a species absent before disinfection, but recovered after disinfection, while a loss corresponds to a species present before disinfection, but absent after disinfection. Error bars are shown in green; p-value = 0.0003 with Mann-Whitney test.
Proteobacteria and Synergistetes (Appendix 3). Of the 59 bacterial species absent from this study, 6 were actually collected from samples prior to ethanol disinfection (i.e., as part of the 18 standard culture conditions), suggesting that they did not survive the disinfection procedure (i.e., LactobacilIus rhamnosus, Faecalibacterium prausnitzii, Acidaminococcus intestinalis, Dorea longicatena, Streptococcus mitis and Lactobacillus paracasei) (Appendix 1, Appendix 3).
Succinate production. As high levels of succinate within the gut microbiota could promote CDI 7 , we assessed the ability from bacteria isolated as part of this study to produce succinate. Considering the species cultured following ethanol disinfection or not, we obtained information for 158/427 species. Of these, 112 were succinate-producing bacteria and 46 were non-succinate-producing bacteria (Appendix 2). However, no significant difference was observed in the impact of ethanol disinfection on succinate-producing species compared to species unable to produce succinate (Mann-Whitney test; p = 0.7693) ( Fig. 6 ).
New species.
The new genera and species found in this study were all found for the first time in fresh stools and were named as follows: . None of these species were found in the 3 fecal infusions.
Discussion
Herein, we carried out a complete culture analysis of 11 fecal samples after ethanol treatment using a culturomics approach that will then be used as bacteriotherapy, particularly for patients with Clostridium difficile infections (CDI). As a result, we cultured a total of 254 species mostly anaerobic, of which 68 bacterial species (containing 9 new bacterial taxa) were obtained only after treatment with ethanol (Appendix 1).
As disinfection technique has already been reported in a bacteriotherapy trial for the treatment of Clostridium difficile infections 18 , in particular for the selection of sporulated bacteria 21 , the primary aim of this study was to identify potential bacterial species that could be used for bacteriotherapy trials through the culturomics approach 22, 23 . Secondly, this work could be used to assess the potential relevance of this culture condition to cultural studies.
Focusing on the contribution of the culturomics strategy to the recapture of bacteria of interest in bacteriotherapy, we found that, compared to previous studies, 23 bacterial genera are shared between the two groups, with 85 bacterial genera representing at least 242 species being reported only in this study ( Fig. 5A-C, Appendix 3 ). This large difference can be explained on the one hand, by the size of our sampling, which is much more important than in the previous studies, and, on the other hand, by our culturomics strategy, which targets the cultivation of a large Grouped comparison of all bacterial species previously known in bacteriotherapy against those of this study; 12 bacterial species are shared between these two groups; these are: Clostridium ramosum, Enterococcus fecalis, Clostridium bifermentans, Escherichia coli, Collinsella aerofaciens, Clostridium innocuum, Bifidobacterium longum, Bacteroides thetaiotaomicron, Bacteroides vulgatus, Bacteroides ovatus, Parabacteroides distasonis and Bifidobacterium adolescentis. (C) Grouped comparison of all previously known bacterial genera in bacteriotherapy against those of this study; 23 bacterial genera are shared between these two groups. [16] [17] [18] [19] [20] and found under culturomics conditions prior ethanol disinfection, were all eliminated after ethanol disinfection protocol. Similarly, the LactobacilIus rhamnosus, Faecalibacterium prausnitzii, Acidaminococcus intestinalis, Dorea longicatena, Streptococcus mitis and Lactobacillus paracasei species do not appear to have survived this disinfection protocol. These findings could appear counterintuitive as Lactobacillus species are frequently included in probiotic formulations for preventing CDI relapses, while Faecalibacterium prausnitzii has been used in a bacteriotherapy trial aiming to eradicate CDI in two patients [16] [17] [18] [19] [20] . As these microbes are often administered in combination 24 , the exact contribution of each of its species to the treatment or prevention of CDI remains undetermined and requires further studies.
When focusing on bacterial taxa dramatically affected by ethanol disinfection, species such as Phascolarctobacterium faecium and Barnesiella intestinihominis (Appendix 2), but also some species of the genera Alistipes, Bacteroides and Bifidobacterium were strongly eliminated (Table 1, Fig. 3 ). Apart from the Bacteroides and Bifidobacterium genera previously reported in bacteriotherapy for the treatment of Clostridium difficile infections, the others have not been found in any bacteriotherapy studies [16] [17] [18] [19] [20] , although it has been reported that many of these anaerobes are described as essential for human intestinal homeostasis [25] [26] [27] [28] [29] . These results may suggest that the majority of these ethanol-eliminated bacterial species would not be fully essential for the treatment of Clostridium difficile infections. Among the genera least affected by ethanol disinfection in this study, Blautia, Clostridium and Lactobacillus were identified as bacteriotherapy candidates for the treatment of Clostridium difficile infections [16] [17] [18] [19] [20] . Indeed, ethanol stool disinfection would therefore select the majority of bacterial genera sufficient to restore the diversity of the gut microbiota in the treatment of Clostridium difficile infections.
Interestingly, ethanol disinfection has enriched the proportion of species belonging to the Ruminococcaceae and Lachnospiraceae (Appendix 1, Appendix 4) . These two bacterial families have been suggested to be predictive of favorable outcome following FMT for treating Clostridium difficile infections 30 . Our list of bacteria obtained with ethanol disinfection is therefore quite consistent and contains probable candidates for CDI bacteriotherapy trials.
Strikingly, sporulated bacterial species only represent 26.53% of all the species gained by ethanol disinfection (Appendix 2), and the majority of species gained at least 3 times are new non-spore forming culturomics species 23 ( Supplementary Table 3 ). This highlights the fact that ethanol disinfection is ultimately an effective approach to recover fastidious and minority species that have not been found under standard culturomics conditions 22, 23 for the same samples and is therefore suitable for the exploration of the human gut microbiota. However, our data do not support the idea that only sporulating species can survive this procedure (Fig. 4) , as previously suggested 18, 21 , even though they have been less affected by ethanol disinfection than non-sporulating species.
Furthermore, some anaerobic bacteria reported in this study produce [31] [32] [33] [34] or consume 28, 35 succinate (Appendix 2). This production of succinate by intestinal bacteria modulates glucose metabolism in the healthy host by inducing activation of intestinal gluconeogenesis 36 . However, in the host suffering from CDI, Clostridium difficile can exploit the succinate produced by converting it into butyrate to multiply and exert an increased Figure 6 . Graphical representation of the mean impact of ethanol disinfection on succinate producers and nonsuccinate producers. We have assessed the mean impact of ethanol disinfection for each species by summing the number of samples for which the species was gained and by subtracting the number of samples for which it was lost. A gain corresponds to a species absent before disinfection, but recovered after disinfection, while a loss corresponds to a species present before disinfection but absent after disinfection. Error bars are shown in green; p-value = 0.7693 with Mann-Whitney test. Error bars are shown in green; p-value = 0.7693 with Mann-Whitney test.
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(2020) 10:5190 | https://doi.org/10.1038/s41598-020-62068-x www.nature.com/scientificreports www.nature.com/scientificreports/ pathogenic effect 7 . In our study, ethanol disinfection has no particular effect on the succinate producing species as they were eliminated by ethanol incubation as much as non-succinate producing species (Fig. 6) .
Finally, considering the gains and losses of stool bacterial species in each stool after ethanol treatment, we noted that 98 minority bacterial species are gained at least once, versus 329 majority species lost at least once (Appendix 2). This suggests a complementarity between standard culturomics conditions and ethanol disinfection conditions for the isolation of high numbers of microorganisms from stool samples. Indeed, ethanol stool disinfection may therefore be an additional condition to be added to our laboratory culture strategy for future studies, to explore and increase the microbial flora not yet cultivated in order to enrich the bacterial repertoire of rare bacterial species. While the alcohol disinfection was empirically designed to select the sporulated bacteria, another point of consideration could be to explore the impact of heat shock on fecal specimen from donors to search for new bacteriotherapy trials candidates.
Conclusion
In conclusion, we demonstrated here that ethanol disinfection associated with the culturomic approach could be a promising approach to explore the diversity of the human gut microbiota by selecting bacterial species of interest, which can be potentially usable in bacteriotherapy. High-scale culture approach applied to 11 samples allowed us to isolate 242 species that have never been reported in previous bacteriotherapy trials and that could be the subject of further studies in the treatment of Clostridium difficile infections.
Material and Methods
Samples information. The material consists of 11 samples of healthy subjects, 8 of which represent fresh stools from fecal transplant donors and 3 were samples of fecal infusion obtained from frozen stools (80 °C). These 11 samples were collected from 9 different fecal donors: the 8 fresh stools represent 8 different donors, fecal infusions 1 and 2 were collected from donors of fresh stools 1 and 4, and fecal infusion 3 was obtained from the ninth donor (Supplementary Table 4 ). Each fecal donor gave informed and signed consent. The study was approved by the ethics committee of the Institut Hospitalo-Universitaire-Méditerranée Infection under agreement number 2016-011 and all the methods were performed in accordance with relevant and regulations.
Standard microbiological procedures. According to the French Recommendations of the National
Agency for the Safety of Medicines (ANSM) 37 , the stool have been qualified before being used for fecal transplantation. This qualification procedure includes the search for pathogens and for transferable resistance mechanisms from the stool and blood of donor. Any positive result to a pathogen or resistance mechanisms precludes the use of this donor's stool (Supplementary Table 5 ).
Preparation of fecal infusion.
Fecal infusion is a stool donation prepared to be transplanted to a receiver, while fecal transplant is the action of transplanting the fecal infusion to a receiver. Between September 2016 and December 2017, 3 different fecal infusions were prepared according to the procedure previously reported 38 and from 3 different frozen fecal transplant donor stools. Donors were, pre-selected from questionnaires and medical tests according to the ANSM 37 (Supplementary Data). Briefly, for the preparation of each fecal infusion, each donor's stool is thawed at room temperature for 4 hours. In a pitcher, 500 mL of saline is added to the stool. The mixture is then mixed for 5 minutes and passed through a sieve having a pore size of 1 mm in diameter. The fecal infusion is collected in 10 mL syringes and then kept under anaerobic conditions (ie in a plastic bag + GENbag Anaer systems (bioMérieux)). Each fecal infusion represents one sample and one donor.
Process. Manipulations of the 11 samples used (8 fresh stools samples and 3 fecal infusions samples) were performed under microbiological hood and anaerobic chamber. Each stool was disinfected separately with ethanol according to a previous study 18 in order to eliminate vegetative forms as much as possible to promote the growth of bacteria resistant to alcohol 18 and capable of sporulating 18, 21 . To this end, about 10 g of each stool was homogenized in 10 mL of saline solution (NaCL 0.9%, Versylene ® Fresenius, Sevres, France). Then, the mixture is filtered through a sieve with a pore size of 1 mm in diameter and the supernatant is recovered. In falcon tubes, 10 mL of 100% ethanol is added to 10 mL of supernatant containing the bacterial cells and the spores. This mixture is then incubated at room temperature under anaerobic conditions for 1 hour. Thereafter, the mixture is centrifuged for 2 minutes at 5000 rpm to remove ethanol (which in this case is the supernatant). The pellet was washed twice with saline solution by centrifugation to remove any trace of the remaining ethanol before proceeding to microbial culturomics.
Microbial culturomics.
After ethanol disinfection of the 11 samples, we performed, the culture on 6 different solid culture media and, on 16 different pre-enrichment conditions ( Supplementary Table 1 ), which will then be subcultured on sheep blood-enriched Columbia agar (COS) medium (bioMérieux, Marcy l'Etoile, France). A total of 22 culture conditions were thereby used in this study. Briefly, the direct culture after ethanol treatment was carried out in anaerobic chamber on these 6 different types of culture media: Reinforced clostridial agar (HiMedia ™ Laboratories Pvt Lt, India), Wilkins Chalgren agar (Becton, Dickinson company, Le Pont-de-Claix, France), Brain-heart infusion agar (Becton, Dickinson company, Le Pont-de-Claix, France), deMan, Rogosa and Sharpe agar (Sigma-Aldrich, Saint-Louis, USA) 16 , 5% sheep blood-enriched columbia agar (COS) (bioMérieux, Marcy l'Etoile, France), Yeast Extract-Casein Hydrolysate-Fatty Acids (YCFA) agar, according to the composition previously described 39 , supplemented with 0.002 g/ml each of glucose, maltose, cellobiose and 0.1% sodium taurocholate 40 . In parallel, the stools were pre-incubated in blood culture bottles supplemented or not with 5% of the rumen, 5% of blood or both under aerobic and anaerobic conditions at 37 °C and then at 28 °C, under 16 selected culturomics conditions 22, 23 . These blood cultures were seeded every 3 days on Columbia agar with 5% sheep blood (bioMérieux, Marcy l'Etoile, France) under aerobic and anaerobic conditions for 30 days 22, 23 
